Merck acquires OncoImmune to ramp supply of promising Covid drug

The medicine, CD24Fc, was shown to reduce the risk of respiratory failure or death by more than 50% in patients hospitalized with Covid and requiring oxygen

from Health and Science https://ift.tt/3lXxOwy
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH